FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mae Gordon

Research Profile

Disorders

Physiology

Concepts & Ideas

Chemicals & Drugs

Antihypertensive Agents

Anatomy

Procedures

Devices

Contact Lenses

Co-author Network

Publications

TOP 3
Linda M Zangwill; James Brandt; George A Cioffi; Anne L Coleman; Keri Dirkes; Mae O Gordon; Feng He; Sonia Jain; Michael A Kass; Jeffrey M Liebmann; Felipe A Medeiros; Jody R Piltz-Seymour; Gary Trick; Robert N Weinreb
The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.
Stuart K Gardiner; Mae O Gordon; Michael A Kass; Shaban Demirel
Seasonal changes in visual field sensitivity and intraocular pressure in the ocular hypertension treatment study.
Stuart K Gardiner; Mae O Gordon; Michael A Kass; Jeffrey M Liebmann; Robert Ritch; George A Cioffi; Carlos Gustavo De Moraes; Shaban Demirel
Series length used during trend analysis affects sensitivity to changes in progression rate in the ocular hypertension treatment study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mae Gordon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Linda M Zangwill; James Brandt; George A Cioffi; Anne L Coleman; Keri Dirkes; Mae O Gordon; Feng He; Sonia Jain; Michael A Kass; Jeffrey M Liebmann; Felipe A Medeiros; Jody R Piltz-Seymour; Gary Trick; Robert N Weinreb
The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.
American journal of ophthalmology 2013;155(6):971-82.
2013: Stuart K Gardiner; Mae O Gordon; Michael A Kass; Shaban Demirel
Seasonal changes in visual field sensitivity and intraocular pressure in the ocular hypertension treatment study.
Ophthalmology 2013;120(4):724-30.
2013: Stuart K Gardiner; Mae O Gordon; Michael A Kass; Jeffrey M Liebmann; Robert Ritch; George A Cioffi; Carlos Gustavo De Moraes; Shaban Demirel
Series length used during trend analysis affects sensitivity to changes in progression rate in the ocular hypertension treatment study.
Investigative ophthalmology & visual science 2013;54(2):1252-9.
2012: Carlos Gustavo De Moraes; Shaban Demirel; Stuart K Gardiner; Mae O Gordon; Michael A Kass; Jeffrey M Liebmann; Robert Ritch; George A Cioffi
Rate of visual field progression in eyes with optic disc hemorrhages in the ocular hypertension treatment study.
Archives of ophthalmology 2012;130(12):1541-6.
2012: Steven L Mansberger; Brad Wilson; Anjali Bhorade; James Brandt; Mae O Gordon; Henry D Jampel; Michael A Kass
Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study.
Ophthalmology 2012;119(9):1826-31.
2012: Steven M Kymes; Dennis L Lambert; Paul P Lee; David C Musch; Carla J Siegfried; Dustin L Stwalley; Joel Fain; Chris Johnson; Sameer V Kotak; Mae O Gordon
The development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model.
Ophthalmology 2012;119(7):1367-74.
2012: Carlos Gustavo De Moraes; Shaban Demirel; Stuart K Gardiner; Mae O Gordon; Michael A Kass; Jeffrey M Liebmann; Robert Ritch; George A Cioffi
Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group.
Investigative ophthalmology & visual science 2012;53(4):1704-9.
2012: James Brandt; Feng Gao; Mae O Gordon; Michael A Kass; J. Philip Miller; Julia A Beiser
Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.
Ophthalmology 2012;119(3):437-42.
2012: Feng Gao; Julia A Beiser; Michael A Kass; Stefano Miglior; J Philip Miller; Valter Torri; Mae O Gordon
The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis.
BMC medical research methodology 2012;12():151.
2012: Shaban Demirel; Stuart K Gardiner; Mae O Gordon; Michael A Kass; Jeffrey M Liebmann; Robert Ritch; George A Cioffi; Carlos Gustavo V De Moraes
The rate of visual field change in the ocular hypertension treatment study.
Investigative ophthalmology & visual science 2012;53(1):224-7.
2011: Ronald L Rebenitsch; Steven M Kymes; Jeffrey J Walline; Mae O Gordon
The lifetime economic burden of keratoconus: a decision analysis using a markov model.
American journal of ophthalmology 2011;151(5):768-773.e2.
2011: Melike Pekmezci; Sidney T Chang; Bradley S Wilson; Mae O Gordon; Anjali M Bhorade
Effect of measurement order between right and left eyes on intraocular pressure measurement.
Archives of ophthalmology 2011;129(3):276-81.
2010: Paul H Artes; Balwantray C Chauhan; John L Keltner; Kimberly E Cello; Chris A Johnson; Douglas R Anderson; Mae O Gordon; Michael A Kass
Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study.
Archives of ophthalmology 2010;128(12):1528-32.
2010: Anjali M Bhorade; Bradley S Wilson; Mae O Gordon; Paul F Palmberg; Robert N Weinreb; Eydie Miller; Robert Chang; Michael A Kass
The utility of the monocular trial: data from the ocular hypertension treatment study.
Ophthalmology 2010;117(11):2047-54.
2010: Robert N Weinreb; Linda M Zangwill; Sonia Jain; Lida M Becerra; Keri Dirkes; Jody R Piltz-Seymour; George A Cioffi; Gary L Trick; Anne L Coleman; James Brandt; Jefferey M Liebmann; Mae O Gordon; Michael A Kass
Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study.
Ophthalmology 2010;117(9):1674-83.
2010: Steven M Kymes; Michael R Plotzke; Michael A Kass; Michael Boland; Mae O Gordon
Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension.
Archives of ophthalmology 2010;128(5):613-8.
2010: Michael A Kass; Mae O Gordon; Feng Gao; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J. Philip Miller; Richard K Parrish; M Roy Wilson
Delaying treatment of ocular hypertension: the ocular hypertension treatment study.
Archives of ophthalmology 2010;128(3):276-87.
2010: Edward M Barnett; Aldo Fantin; Bradley S Wilson; Michael A Kass; Mae O Gordon
The incidence of retinal vein occlusion in the ocular hypertension treatment study.
Ophthalmology 2010;117(3):484-8.
2009: Anjali M Bhorade; Mae O Gordon; Brad Wilson; Robert N Weinreb; Robert N Weinrab; Michael A Kass
Variability of intraocular pressure measurements in observation participants in the ocular hypertension treatment study.
Ophthalmology 2009;116(4):717-24.
2008: James Brandt; Mae O Gordon; Julia A Beiser; Shan C Lin; Monica Y Alexander; Michael A Kass
Changes in central corneal thickness over time: the ocular hypertension treatment study.
Ophthalmology 2008;115(9):1550-6, 1556.e1.
2008: Michael A Kass; Mae O Gordon
Diabetes and glaucoma.
Archives of ophthalmology 2008;126(5):746-7.
2008: Bryan S Lee; Steven M Kymes; Robert F Nease; Walton Sumner; Carla J Siegfried; Mae O Gordon
The impact of anchor point on utilities for 5 common ophthalmic diseases.
Ophthalmology 2008;115(5):898-903.e4.
2008: Steven M Kymes; Jeffrey J Walline; Karla Zadnik; John Sterling; Mae O Gordon
Changes in the quality-of-life of people with keratoconus.
American journal of ophthalmology 2008;145(4):611-617.
2008: Mae O Gordon; Julia A Beiser; Michael A Kass
Is a history of diabetes mellitus protective against developing primary open-angle glaucoma?
Archives of ophthalmology 2008;126(2):280-1.
2007: John L Keltner; Chris A Johnson; Kimberly E Cello; Shannan E Bandermann; Juanjuan Fan; Richard A Levine; Michael A Kass; Mae O Gordon
Visual field quality control in the Ocular Hypertension Treatment Study (OHTS).
Journal of glaucoma 2007;16(8):665-9.
2007: Xianmin Luo; Steven M Kymes; Mae O Gordon; Steven Bassnett
Lens fluorescence and accommodative amplitude in pre-presbyopic and presbyopic subjects.
Experimental eye research 2007;84(5):1013-7.
2007: Steven L Mansberger; Bret A Hughes; Mae O Gordon; Steven D Spaner; Julia A Beiser; George A Cioffi; Michael A Kass
Comparison of initial intraocular pressure response with topical beta-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study.
Archives of ophthalmology 2007;125(4):454-9.
2007: Mae O Gordon; Valter Torri; Stefano Miglior; Julia A Beiser; Irene Floriani; J. Philip Miller; Feng Gao; Ingrid Adamsons; Davide Poli; Ralph B D'Agostino; Michael A Kass
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.
Ophthalmology 2007;114(1):10-9.
2006: Mae O Gordon; Karen Steger-May; Loretta Szczotka-Flynn; Colleen Riley; Charlotte E Joslin; Barry A Weissman; Barbara A Fink; Timothy B Edrington; Harald E Olafsson; Karla Zadnik
Baseline factors predictive of incident penetrating keratoplasty in keratoconus.
American journal of ophthalmology 2006;142(6):923-30.
2006: Donald L Budenz; Douglas R Anderson; William J Feuer; Julia A Beiser; Joyce C. Schiffman; Richard K Parrish; Jody R Piltz-Seymour; Mae O Gordon; Michael A Kass
Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study.
Ophthalmology 2006;113(12):2137-43.
2006: David C Herman; Mae O Gordon; Julia A Beiser; Leo T Chylack; Kathleen A Lamping; Oliver D Schein; Joern B Soltau; Michael A Kass
Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study.
American journal of ophthalmology 2006;142(5):800-10.
2006: John L Keltner; Chris A Johnson; Douglas R Anderson; Richard A Levine; Juanjuan Fan; Kimberly E Cello; Harry A Quigley; Donald L Budenz; Richard K Parrish; Michael A Kass; Mae O Gordon
The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.
Ophthalmology 2006;113(9):1603-12.
2006: Steven M Kymes; Michael A Kass; Douglas R Anderson; J. Philip Miller; Mae O Gordon
Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
American journal of ophthalmology 2006;141(6):997-1008.
2006: Larry J Davis; Kenneth B Schechtman; Brad S Wilson; Carol E Rosenstiel; Colleen H Riley; David P Libassi; Ralph E Gundel; Louis Rosenberg; Mae O Gordon; Karla Zadnik
Longitudinal changes in visual acuity in keratoconus.
Investigative ophthalmology & visual science 2006;47(2):489-500.
2006: Joseph T Barr; Brad S Wilson; Mae O Gordon; Marjorie J Rah; Colleen Riley; Pete S Kollbaum; Karla Zadnik
Estimation of the incidence and factors predictive of corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study.
Cornea 2006;25(1):16-25.
2005: Karla Zadnik; Joseph T Barr; Karen Steger-May; Timothy B Edrington; Timothy T McMahon; Mae O Gordon
Comparison of flat and steep rigid contact lens fitting methods in keratoconus.
Optometry and vision science : official publication of the American Academy of Optometry 2005;82(12):1014-21.
2005: Richard K Parrish; Joyce C. Schiffman; William J Feuer; Douglas R Anderson; Donald L Budenz; Maria-Cristina Wells-Albornoz; Ruth Vandenbroucke; Michael A Kass; Mae O Gordon
Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders.
American journal of ophthalmology 2005;140(4):762-4.
2005: John L Keltner; Chris A Johnson; Richard A Levine; Juanjuan Fan; Kimberly E Cello; Michael A Kass; Mae O Gordon
Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.
Archives of ophthalmology 2005;123(9):1201-6.
2005: Linda M Zangwill; Robert N Weinreb; Julia A Beiser; Charles C Berry; George A Cioffi; Anne L Coleman; Gary Trick; Jeffrey M Liebmann; James Brandt; Jody R Piltz-Seymour; Keri A Dirkes; Suzanne Vega; Michael A Kass; Mae O Gordon
Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.
Archives of ophthalmology 2005;123(9):1188-97.
2005: Barbara A Fink; Heidi Wagner; Karen Steger-May; Carol E Rosenstiel; Teresa Roediger; Timothy T McMahon; Mae O Gordon; Karla Zadnik
Differences in keratoconus as a function of gender.
American journal of ophthalmology 2005;140(3):459-68.
2005: Michael A Kass; Mae O Gordon; Steven M Kymes
Incorporating the results of the Ocular Hypertension Treatment Study into clinical practice.
Archives of ophthalmology 2005;123(7):1021-2.
2004: James Brandt; Julia A Beiser; Mae O Gordon; Michael A Kass
Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
American journal of ophthalmology 2004;138(5):717-22.
2004: Anne L Coleman; Mae O Gordon; Julia A Beiser; Michael A Kass
Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.
American journal of ophthalmology 2004;138(4):684-5.
2004: Steven M Kymes; Jeffrey J Walline; Karla Zadnik; Mae O Gordon
Quality of life in keratoconus.
American journal of ophthalmology 2004;138(4):527-35.
2004: Eve J Higginbotham; Mae O Gordon; Julia A Beiser; Michael V Drake; G Richard Bennett; M R Wilson; Michael A Kass
The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals.
Archives of ophthalmology 2004;122(6):813-20.
2004: Timothy B Edrington; Ralph E Gundel; David P Libassi; Heidi Wagner; Gilbert E Pierce; Jeffrey J Walline; Joseph T Barr; Harald E Olafsson; Karen Steger-May; Joel Achtenberg; Brad S Wilson; Mae O Gordon; Karla Zadnik
Variables affecting rigid contact lens comfort in the collaborative longitudinal evaluation of keratoconus (CLEK) study.
Optometry and vision science : official publication of the American Academy of Optometry 2004;81(3):182-8.
2004: Linda M Zangwill; Robert N Weinreb; Charles C Berry; Amanda R Smith; Keri A Dirkes; Jeffrey M Liebmann; James Brandt; Gary Trick; George A Cioffi; Anne L Coleman; Jody R Piltz-Seymour; Mae O Gordon; Michael A Kass
The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors.
American journal of ophthalmology 2004;137(2):219-27.
2004: Linda M Zangwill; Robert N Weinreb; Charles C Berry; Amanda R Smith; Keri A Dirkes; Anne L Coleman; Jody R Piltz-Seymour; Jeffrey M Liebmann; George A Cioffi; Gary Trick; James Brandt; Mae O Gordon; Michael A Kass
Racial differences in optic disc topography: baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.
Archives of ophthalmology 2004;122(1):22-8.
2004: George J Harocopos; Ying-Bo Shui; Megan McKinnon; Nancy M Holekamp; Mae O Gordon; David C Beebe
Importance of vitreous liquefaction in age-related cataract.
Investigative ophthalmology & visual science 2004;45(1):77-85.
2003: John L Keltner; Chris A Johnson; Kimberly E Cello; Mary A Edwards; Shannan E Bandermann; Michael A Kass; Mae O Gordon
Classification of visual field abnormalities in the ocular hypertension treatment study.
Archives of ophthalmology 2003;121(5):643-50.
2002: Mae O Gordon; Julia A Beiser; James Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J. Philip Miller; Richard K Parrish; M R Wilson; Michael A Kass
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.
Archives of ophthalmology 2002;120(6):714-20; discussion 829-30.
2002: Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J. Philip Miller; Richard K Parrish; M R Wilson; Mae O Gordon
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
Archives of ophthalmology 2002;120(6):701-13; discussion 829-30.
2002: Chris A Johnson; John L Keltner; Kimberly E Cello; Mary Edwards; Michael A Kass; Mae O Gordon; Donald L Budenz; Douglas E Gaasterland; Elliot Werner
Baseline visual field characteristics in the ocular hypertension treatment study.
Ophthalmology 2002;109(3):432-7.
2002: William J Feuer; Richard K Parrish; Joyce C. Schiffman; Douglas R Anderson; Donald L Budenz; Maria-Cristina Wells; Ditte J Hess; Michael A Kass; Mae O Gordon
The Ocular Hypertension Treatment Study: reproducibility of cup/disk ratio measurements over time at an optic disc reading center.
American journal of ophthalmology 2002;133(1):19-28.
2001: James Brandt; Julia A Beiser; Michael A Kass; Mae O Gordon
Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).
Ophthalmology 2001;108(10):1779-88.
2000: Karla Zadnik; Joseph T Barr; Timothy B Edrington; Jason J Nichols; Brad S Wilson; K Siegmund; Mae O Gordon
Corneal scarring and vision in keratoconus: a baseline report from the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study.
Cornea 2000;19(6):804-12.
2000: Michael A Kass; Mae O Gordon
Intraocular pressure and visual field progression in open-angle glaucoma.
American journal of ophthalmology 2000;130(4):490-1.
2000: JR Piltz; R Gross; Dong H Shin; Julia A Beiser; David A Dorr; Michael A Kass; Mae O Gordon
Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study.
American journal of ophthalmology 2000;130(4):441-53.
2000: John L Keltner; Chris A Johnson; J M Quigg; Kimberly E Cello; Michael A Kass; Mae O Gordon
Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group.
Archives of ophthalmology 2000;118(9):1187-94.
2000: Joseph T Barr; Karla Zadnik; Brad S Wilson; Timothy B Edrington; D F Everett; Barbara A Fink; J P Shovlin; Barry A Weissman; K Siegmund; Mae O Gordon
Factors associated with corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study.
Cornea 2000;19(4):501-7.
1999: Timothy B Edrington; Loretta B Szczotka; Joseph T Barr; J F Achtenberg; D S Burger; A M Janoff; Harald E Olafsson; M W Chun; J W Boyle; Mae O Gordon; Karla Zadnik
Rigid contact lens fitting relationships in keratoconus. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group.
Optometry and vision science : official publication of the American Academy of Optometry 1999;76(10):692-9.
1999: Mae O Gordon; Michael A Kass
The Ocular Hypertension Treatment Study: design and baseline description of the participants.
Archives of ophthalmology 1999;117(5):573-83.
1999: Joseph T Barr; Kenneth B Schechtman; Barbara A Fink; Gilbert E Pierce; C D Pensyl; Karla Zadnik; Mae O Gordon
Corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: baseline prevalence and repeatability of detection.
Cornea 1999;18(1):34-46.
1998: Karla Zadnik; Joseph T Barr; Timothy B Edrington; D F Everett; M Jameson; Timothy T McMahon; JA Shin; J L Sterling; H Wagner; Mae O Gordon
Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study.
Investigative ophthalmology & visual science 1998;39(13):2537-46.
1998: Timothy B Edrington; Loretta B Szczotka; C G Begley; D S Burger; Brad S Wilson; Joseph T Barr; Karla Zadnik; Mae O Gordon
Repeatability and agreement of two corneal-curvature assessments in keratoconus: keratometry and the first definite apical clearance lens (FDACL). CLEK Study Group. Collaborative Longitudinal Evaluation of Keratoconus.
Cornea 1998;17(3):267-77.
1998: Mae O Gordon; Kenneth B Schechtman; Larry J Davis; Timothy T McMahon; J Schornack; Karla Zadnik
Visual acuity repeatability in keratoconus: impact on sample size. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group.
Optometry and vision science : official publication of the American Academy of Optometry 1998;75(4):249-57.
1996: R E Gundel; D P Libassi; Karla Zadnik; Joseph T Barr; L Davis; Timothy T McMahon; Timothy B Edrington; Mae O Gordon
Feasibility of fitting contact lenses with apical clearance in keratoconus.
Optometry and vision science : official publication of the American Academy of Optometry 1996;73(12):729-32.
1996: Timothy B Edrington; Joseph T Barr; Karla Zadnik; L J Davis; R E Gundel; D P Libassi; Timothy T McMahon; Mae O Gordon
Standardized rigid contact lens fitting protocol for keratoconus.
Optometry and vision science : official publication of the American Academy of Optometry 1996;73(6):369-75.
1996: Joseph T Barr; Mae O Gordon; Karla Zadnik; K Pellican; Timothy B Edrington
Photodocumentation of corneal scarring. Collaborative Longitudinal Evaluation of Keratoconus Study Group.
Journal of refractive surgery (Thorofare, N.J. : 1995) 1996;12(4):492-500.
1996: Karla Zadnik; Joseph T Barr; Mae O Gordon; Timothy B Edrington
Biomicroscopic signs and disease severity in keratoconus. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group.
Cornea 1996;15(2):139-46.
1994: Kenneth B Schechtman; Mae O Gordon
The effect of poor compliance and treatment side effects on sample size requirements in randomized clinical trials.
Journal of biopharmaceutical statistics 1994;4(2):223-32.
1993: Mae O Gordon; Michael A Kass
Ocular hypertension treatment study: design issues.
Journal of glaucoma 1993;2 Suppl A():24-5.
1993: Michael A Kass; Mae O Gordon; M R Hoff; J M Parkinson; AE Kolker; WM Hart; B Becker
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (1).
Journal of glaucoma 1993;2 Suppl A():1-2.